Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy
- 31 December 1994
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 21 (1) , 81-87
- https://doi.org/10.1016/s0168-8278(94)80141-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliterationGastroenterology, 1992
- Beta-blockers for preventing variceal bleedingThe Lancet, 1990
- Meta-analysis of value of propranolol in prevention of variceal haemorrhageThe Lancet, 1990
- Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliterationHepatology, 1986
- A Randomized Controlled Trial of Variceal Compression as an Adjunct to Endoscopic Variceal SclerosisScandinavian Journal of Gastroenterology, 1986
- Improved Survival Following Injection Sclerotherapy for Esophageal Varices: Final Analysis of A Controlled TrialHepatology, 1985
- Sclerotherapy after First Variceal Hemorrhage in CirrhosisNew England Journal of Medicine, 1984
- A Randomized Controlled Study of Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with Cirrhosis: A Final ReportHepatology, 1984
- Propranolol for Prevention of Recurrent Gastrointestinal Bleeding in Patients with CirrhosisNew England Journal of Medicine, 1981
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973